Skip to content

ENGNW

enGene Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$0.20
−13.04%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
1.56x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
0.04x
Price / sales
Price / cash flow
-0.10x

Enterprise value

Enterprise value
-$222.8M
EV / sales
EV / EBITDA
1.69x
EV / EBIT
47.57x
Market cap
$10.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026